GlaxoSmithKline PLC ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $36.57
- Today's High:
- $36.995
- Open Price:
- $36.96
- 52W Low:
- $27.3676
- 52W High:
- $38.5796
- Prev. Close:
- $37.02
- Volume:
- 3128917
Company Statistics
- Market Cap.:
- $74.84 billion
- Book Value:
- 6.262
- Revenue TTM:
- $29.33 billion
- Operating Margin TTM:
- 27.17%
- Gross Profit TTM:
- $19.92 billion
- Profit Margin:
- 52.6%
- Return on Assets TTM:
- 6.71%
- Return on Equity TTM:
- 33.22%
Company Profile
GlaxoSmithKline PLC ADR had its IPO on 1986-07-09 under the ticker symbol GSK.
The company operates in the Healthcare sector and Drug Manufacturers-General industry. GlaxoSmithKline PLC ADR has a staff strength of 69,400 employees.
Stock update
Shares of GlaxoSmithKline PLC ADR opened at $36.96 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $36.57 - $37, and closed at $36.86.
This is a -0.43% slip from the previous day's closing price.
A total volume of 3,128,917 shares were traded at the close of the day’s session.
In the last one week, shares of GlaxoSmithKline PLC ADR have increased by +5.22%.
GlaxoSmithKline PLC ADR's Key Ratios
GlaxoSmithKline PLC ADR has a market cap of $74.84 billion, indicating a price to book ratio of 6.5494 and a price to sales ratio of 1.8639.
In the last 12-months GlaxoSmithKline PLC ADR’s revenue was $29.33 billion with a gross profit of $19.92 billion and an EBITDA of $9.87 billion. The EBITDA ratio measures GlaxoSmithKline PLC ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, GlaxoSmithKline PLC ADR’s operating margin was 27.17% while its return on assets stood at 6.71% with a return of equity of 33.22%.
In Q2, GlaxoSmithKline PLC ADR’s quarterly earnings growth was a positive 92.3% while revenue growth was a positive 3.6%.
GlaxoSmithKline PLC ADR’s PE and PEG Ratio
- Forward PE
- 9.8039
- Trailing PE
- 11.53
- PEG
- 1.1245
Its diluted EPS in the last 12-months stands at $3.17 per share while it has a forward price to earnings multiple of 9.8039 and a PEG multiple of 1.1245. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into GlaxoSmithKline PLC ADR’s profitability.
GlaxoSmithKline PLC ADR stock is trading at a EV to sales ratio of 2.3636 and a EV to EBITDA ratio of 9.2668. Its price to sales ratio in the trailing 12-months stood at 1.8639.
GlaxoSmithKline PLC ADR stock pays annual dividends of $0.555 per share, indicating a yield of 3.83% and a payout ratio of 38.21%.
Balance sheet and cash flow metrics
- Total Assets
- $59.46 billion
- Total Liabilities
- $22.11 billion
- Operating Cash Flow
- $-1372000000.00
- Capital Expenditure
- $535 million
- Dividend Payout Ratio
- 38.21%
GlaxoSmithKline PLC ADR ended 2024 with $59.46 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $59.46 billion while shareholder equity stood at $12.69 billion.
GlaxoSmithKline PLC ADR ended 2024 with $0 in deferred long-term liabilities, $22.11 billion in other current liabilities, 1348000000.00 in common stock, $6.42 billion in retained earnings and $6.72 billion in goodwill. Its cash balance stood at $3.14 billion and cash and short-term investments were $6.50 billion. The company’s total short-term debt was $5,921,000,000 while long-term debt stood at $15.55 billion.
GlaxoSmithKline PLC ADR’s total current assets stands at $19.35 billion while long-term investments were $0 and short-term investments were $3.36 billion. Its net receivables were $6.78 billion compared to accounts payable of $13.95 billion and inventory worth $5.51 billion.
In 2024, GlaxoSmithKline PLC ADR's operating cash flow was $-1372000000.00 while its capital expenditure stood at $535 million.
Comparatively, GlaxoSmithKline PLC ADR paid $0.38 in dividends in 2024.
Other key metrics
- Current Trading Price
- $36.86
- 52-Week High
- $38.5796
- 52-Week Low
- $27.3676
- Analyst Target Price
- $39.63
GlaxoSmithKline PLC ADR stock is currently trading at $36.86 per share. It touched a 52-week high of $38.5796 and a 52-week low of $38.5796. Analysts tracking the stock have a 12-month average target price of $39.63.
Its 50-day moving average was $34.81 and 200-day moving average was $34.68 The short ratio stood at 1.77 indicating a short percent outstanding of 0%.
Around 4.9% of the company’s stock are held by insiders while 1359.6% are held by institutions.
Frequently Asked Questions About GlaxoSmithKline PLC ADR
Similar Industry Stocks (Drug Manufacturers-General)
Most Active
Top Gainers
Top Losers
About
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.